391 related articles for article (PubMed ID: 29078805)
1. CRISPR/Cas9-Correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer's PSEN2
Ortiz-Virumbrales M; Moreno CL; Kruglikov I; Marazuela P; Sproul A; Jacob S; Zimmer M; Paull D; Zhang B; Schadt EE; Ehrlich ME; Tanzi RE; Arancio O; Noggle S; Gandy S
Acta Neuropathol Commun; 2017 Oct; 5(1):77. PubMed ID: 29078805
[TBL] [Abstract][Full Text] [Related]
2. iPSC-derived familial Alzheimer's PSEN2
Moreno CL; Della Guardia L; Shnyder V; Ortiz-Virumbrales M; Kruglikov I; Zhang B; Schadt EE; Tanzi RE; Noggle S; Buettner C; Gandy S
Mol Neurodegener; 2018 Jun; 13(1):33. PubMed ID: 29945658
[TBL] [Abstract][Full Text] [Related]
3. iPSC-derived PSEN2 (N141I) astrocytes and microglia exhibit a primed inflammatory phenotype.
Sullivan MA; Lane SD; McKenzie ADJ; Ball SR; Sunde M; Neely GG; Moreno CL; Maximova A; Werry EL; Kassiou M
J Neuroinflammation; 2024 Jan; 21(1):7. PubMed ID: 38178159
[TBL] [Abstract][Full Text] [Related]
4. A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ.
Kwart D; Gregg A; Scheckel C; Murphy EA; Paquet D; Duffield M; Fak J; Olsen O; Darnell RB; Tessier-Lavigne M
Neuron; 2019 Oct; 104(2):256-270.e5. PubMed ID: 31416668
[TBL] [Abstract][Full Text] [Related]
5. Generation of gene edited hiPSC from familial Alzheimer's disease patient carrying N141I missense mutation in presenilin 2.
Marei HE; Althani A; Afifi N; Hasan A; Caceci T; Pozzoli G; Cenciarelli C
Stem Cell Res; 2021 Oct; 56():102552. PubMed ID: 34634760
[TBL] [Abstract][Full Text] [Related]
6. Presence of a mutation in PSEN1 or PSEN2 gene is associated with an impaired brain endothelial cell phenotype in vitro.
Raut S; Patel R; Al-Ahmad AJ
Fluids Barriers CNS; 2021 Jan; 18(1):3. PubMed ID: 33413468
[TBL] [Abstract][Full Text] [Related]
7. Directed differentiation of basal forebrain cholinergic neurons from human pluripotent stem cells.
Hu Y; Qu ZY; Cao SY; Li Q; Ma L; Krencik R; Xu M; Liu Y
J Neurosci Methods; 2016 Jun; 266():42-9. PubMed ID: 27036311
[TBL] [Abstract][Full Text] [Related]
8. Early-Onset Familial Alzheimer Disease Variant PSEN2 N141I Heterozygosity is Associated with Altered Microglia Phenotype.
Fung S; Smith CL; Prater KE; Case A; Green K; Osnis L; Winston C; Kinoshita Y; Sopher B; Morrison RS; Garden GA; Jayadev S
J Alzheimers Dis; 2020; 77(2):675-688. PubMed ID: 32741831
[TBL] [Abstract][Full Text] [Related]
9. A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer's Disease and Frontotemporal Dementia Disease Modeling.
Muñoz SS; Engel M; Balez R; Do-Ha D; Cabral-da-Silva MC; Hernández D; Berg T; Fifita JA; Grima N; Yang S; Blair IP; Nicholson G; Cook AL; Hewitt AW; Pébay A; Ooi L
Cells; 2020 Sep; 9(9):. PubMed ID: 32887382
[TBL] [Abstract][Full Text] [Related]
10. Stem cell derived basal forebrain cholinergic neurons from Alzheimer's disease patients are more susceptible to cell death.
Duan L; Bhattacharyya BJ; Belmadani A; Pan L; Miller RJ; Kessler JA
Mol Neurodegener; 2014 Jan; 9():3. PubMed ID: 24401693
[TBL] [Abstract][Full Text] [Related]
11. Establishment of induced pluripotent stem cell line (ZZUi010-A) from an Alzheimer's disease patient carrying an APP gene mutation.
Wang Z; Zhang P; Wang Y; Shi C; Jing N; Sun H; Yang J; Liu Y; Wen X; Zhang J; Zhang S; Xu Y
Stem Cell Res; 2017 Dec; 25():213-216. PubMed ID: 29156377
[TBL] [Abstract][Full Text] [Related]
12. Early pathogenic event of Alzheimer's disease documented in iPSCs from patients with PSEN1 mutations.
Yang J; Zhao H; Ma Y; Shi G; Song J; Tang Y; Li S; Li T; Liu N; Tang F; Gu J; Zhang L; Zhang Z; Zhang X; Jin Y; Le W
Oncotarget; 2017 Jan; 8(5):7900-7913. PubMed ID: 27926491
[TBL] [Abstract][Full Text] [Related]
13. Identification of PSEN2 mutation p.N141I in Argentine pedigrees with early-onset familial Alzheimer's disease.
Muchnik C; Olivar N; Dalmasso MC; Azurmendi PJ; Liberczuk C; Morelli L; Brusco LI
Neurobiol Aging; 2015 Oct; 36(10):2674-7.e1. PubMed ID: 26166204
[TBL] [Abstract][Full Text] [Related]
14. Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.
Baker-Nigh A; Vahedi S; Davis EG; Weintraub S; Bigio EH; Klein WL; Geula C
Brain; 2015 Jun; 138(Pt 6):1722-37. PubMed ID: 25732182
[TBL] [Abstract][Full Text] [Related]
15. Generation and characterization of an iPS cell line (PUMCi006-A) from skin fibroblasts of a patient with an M239T mutation in PSEN2 gene.
Zhu W; Zhou J; Shang L; Zhou Y; Wang Q; Yu Y; Dong L; Mao C; Chu S; Jin W; Li J; Gao J
Stem Cell Res; 2024 Jun; 77():103391. PubMed ID: 38531230
[TBL] [Abstract][Full Text] [Related]
16. Genome-editing applications of CRISPR-Cas9 to promote in vitro studies of Alzheimer's disease.
Giau VV; Lee H; Shim KH; Bagyinszky E; An SSA
Clin Interv Aging; 2018; 13():221-233. PubMed ID: 29445268
[TBL] [Abstract][Full Text] [Related]
17. Efficient manipulation of gene dosage in human iPSCs using CRISPR/Cas9 nickases.
Ye T; Duan Y; Tsang HWS; Xu H; Chen Y; Cao H; Chen Y; Fu AKY; Ip NY
Commun Biol; 2021 Feb; 4(1):195. PubMed ID: 33580208
[TBL] [Abstract][Full Text] [Related]
18. ESC-Derived Basal Forebrain Cholinergic Neurons Ameliorate the Cognitive Symptoms Associated with Alzheimer's Disease in Mouse Models.
Yue W; Li Y; Zhang T; Jiang M; Qian Y; Zhang M; Sheng N; Feng S; Tang K; Yu X; Shu Y; Yue C; Jing N
Stem Cell Reports; 2015 Nov; 5(5):776-790. PubMed ID: 26489896
[TBL] [Abstract][Full Text] [Related]
19. Modeling familial Alzheimer's disease with induced pluripotent stem cells.
Yagi T; Ito D; Okada Y; Akamatsu W; Nihei Y; Yoshizaki T; Yamanaka S; Okano H; Suzuki N
Hum Mol Genet; 2011 Dec; 20(23):4530-9. PubMed ID: 21900357
[TBL] [Abstract][Full Text] [Related]
20. [Modeling familial Alzheimer's disease with induced pluripotent stem cells].
Yagi T; Ito D; Okada Y; Akamatsu W; Nihei Y; Okano H; Suzuki N
Rinsho Shinkeigaku; 2012; 52(11):1134-6. PubMed ID: 23196540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
